剰余金の配当（中間配当）、有価証券及び投資有価証券の取得による支出、減価償却費 - 日本他2件
- 【期間】
| 年度 | 剰余金の配当（中間配当） | 有価証券及び投資有価証券の取得による支出 | 減価償却費 - 日本 | 当期変動額合計 | 売上収益 - 医薬 |
|---|
| 2008/12 | - | | -21.4億 | | - | | - | | - | |
| 2009/12 | - | | -1373億 | 赤拡 | - | | - | | - | |
| 2010/03 | - | | -3.08億 | 赤縮 | - | | - | | - | |
| 2010/06 | - | | -3.83億 | 赤拡 | - | | - | | - | |
| 2010/09 | - | | -865億 | 赤拡 | - | | - | | - | |
| 2010/12 | - | | -870億 | 赤拡 | - | | - | | - | |
| 2011/03 | - | | -81.9億 | 赤縮 | - | | - | | - | |
| 2011/06 | - | | -43.4億 | 赤縮 | - | | - | | - | |
| 2011/09 | - | | -2464億 | 赤拡 | - | | - | | - | |
| 2011/12 | -130億 | | -443億 | 赤縮 | - | | 21.7億 | | - | |
| 2012/06 | - | | -46.1億 | 赤縮 | - | | - | | - | |
| 2012/12 | -130億 | 赤縮 | -96.4億 | 赤拡 | 434億 | | - | | - | |
| 2013/06 | - | | -24.6億 | 赤縮 | - | | - | | - | |
| 2013/12 | - | | -44.2億 | 赤拡 | 381億 | -12.1% | - | | - | |
| 2014/06 | - | | -81.5億 | 赤拡 | - | | - | | - | |
| 2014/12 | - | | -267億 | 赤拡 | 352億 | -7.7% | - | | - | |
| 2015/06 | - | | -57.4億 | 赤縮 | - | | - | | - | |
| 2015/12 | - | | -107億 | 赤拡 | 341億 | -3% | - | | - | |
| 2016/06 | - | | -55.4億 | 赤縮 | - | | - | | - | |
| 2016/12 | - | | -208億 | 赤拡 | 230億 | -32.6% | - | | - | |
| 2017/06 | - | | -109億 | 赤縮 | - | | - | | - | |
| 2018/12 | - | | - | | - | | - | | 2715億 | |
| 2019/03 | - | | - | | - | | - | | 758億 | -72.1% |
| 2019/06 | - | | - | | - | | - | | 1514億 | +99.7% |
| 2019/09 | - | | - | | - | | - | | 2255億 | +48.9% |
| 2019/12 | - | | - | | - | | - | | 3058億 | +35.6% |
| 2020/03 | - | | - | | - | | - | | 773億 | -74.7% |
| 2020/06 | - | | - | | - | | - | | 1578億 | +104.2% |
| 2020/09 | - | | - | | - | | - | | 2340億 | +48.3% |
| 2020/12 | - | | - | | - | | - | | 3184億 | +36% |
| 2021/03 | - | | - | | - | | - | | 811億 | -74.5% |
| 2021/06 | - | | - | | - | | - | | 1650億 | +103.4% |
| 2021/09 | - | | - | | - | | - | | 2540億 | +53.9% |
| 2021/12 | - | | - | | - | | - | | 3522億 | +38.7% |
| 2022/03 | - | | - | | - | | - | | 878億 | -75.1% |
| 2022/06 | - | | - | | - | | - | | 1853億 | +111.1% |
| 2022/09 | - | | - | | - | | - | | 2838億 | +53.2% |
| 2022/12 | - | | - | | - | | - | | 3984億 | +40.4% |
| 2023/03 | - | | - | | - | | - | | 935億 | -76.5% |
| 2023/06 | - | | - | | - | | - | | 1992億 | +113% |
| 2023/09 | - | | - | | - | | - | | 3061億 | +53.6% |
| 2023/12 | - | | - | | - | | - | | 4422億 | +44.5% |
| 2024/03 | - | | - | | - | | - | | 1056億 | -76.1% |
| 2024/06 | - | | - | | - | | - | | 2330億 | +120.7% |
